Inventor · disambiguated record
Nikolai Eroshenko
Also filed as: EROSHENKO NIKOLAI · EROSHENKO NIKOLAI A
11 granted patents·8 pending applications·20 citations·filing 2011–2025
85Inventor score
Top patents by PatentIndex Score
19 records- 0191US12098369B2Modified ribonucleic acids and uses thereofHELIX NANOTECHNOLOGIES INC·Filed 2022·Granted Sep 24, 2024·1 cites·28 claims
- 0291US12091663B2Modified ribonucleic acids and uses thereofHELIX NANOTECHNOLOGIES INC·Filed 2023·Granted Sep 17, 2024·1 cites·28 claims
- 0391US11639501B2Modified ribonucleic acids and uses thereofHELIX NANOTECHNOLOGIES INC·Filed 2022·Granted May 2, 2023·3 cites·30 claims
- 0490US11771758B2Compositions including SBI adjuvants and methods of use thereofHELIX NANOTECHNOLOGIES INC·Filed 2022·Granted Oct 3, 2023·3 cites·27 claims
- 0590US9777262B2Mutants of Cre recombinaseHARVARD COLLEGE·Filed 2014·Granted Oct 3, 2017·10 cites·7 claims
- 0682US11473090B2Linear covalently closed vectors and related compositions and methods thereofHELIX NANOTECHNOLOGIES INC·Filed 2018·Granted Oct 18, 2022·2 cites·8 claims
- 0779US12343392B2Compositions including Sbi adjuvants and methods of use thereofHELIX NANOTECHNOLOGIES INC·Filed 2023·Granted Jul 1, 2025·0 cites·28 claims
- 0874US2025223621A1Compositions and methods for rna synthesisHELIX NANOTECHNOLOGIES INC·Filed 2024·Application pending·0 cites
- 0971US12215317B2Acetylated ribonucleic acids and uses thereofHELIX NANOTECHNOLOGIES INC·Filed 2023·Granted Feb 4, 2025·0 cites·26 claims
- 1070US2025129364A1Acetylated ribonucleic acids and uses thereofHELIX NANOTECHNOLOGIES INC·Filed 2024·Application pending·0 cites
- 1167US12442004B2Linear covalently closed vectors and related compositions and methods thereofHELIX NANOTECHNOLOGIES INC·Filed 2022·Granted Oct 14, 2025·0 cites·15 claims
- 1265US12139734B2Compositions and methods for RNA synthesisHELIX NANOTECHNOLOGIES INC·Filed 2021·Granted Nov 12, 2024·0 cites·19 claims
- 1356US2025346888A1Promoter proximal sequences and uses thereof for rna manufacturingHELIX NANOTECHNOLOGIES INC·Filed 2025·Application pending·0 cites
- 1454US11987605B2Mutant MYC fusion polypeptides and uses thereofHELIX NANOTECHNOLOGIES INC·Filed 2020·Granted May 21, 2024·0 cites·21 claims
- 1549US2021369759A1METHODS AND COMPOSITIONS FOR NUCLEIC ACID EXPRESSION INVOLVING INHIBITION of NF-kB PATHWAYS AND/OR IRF PATHWAYSHELIX NANOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 1645US2014045728A1Orthogonal Amplification and Assembly of Nucleic Acid SequencesCHURCH GEORGE M·Filed 2011·Application pending·0 cites
- 1743US2021238240A1Methods and compositions for rna expression of myc inhibitorsHELIX NANOTECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 1842US2020224194A1Expression systems that facilitate nucleic acid delivery and methods of useHELIX NANOTECHNOLOGIES INC·Filed 2018·Application pending·0 cites
- 1940US2025270299A1Methods of using compositions comprising sbi domainsHELIX NANOTECHNOLOGIES INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nikolai Eroshenko files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →